10.04.2024 – 11:00Dr. Reddy's Laboratories SADr. Reddy's subsidiary betapharm, and Theranica launch Nerivio® in Germany to provide patients with drug-free migraine treatmentmore
13.03.2024 – 16:21FDX Fluid Dynamix GmbH4FDX Fluid Dynamix and Fraunhofer IPK to Collaborate with Lonza on Novel Nanoparticle Formulation Technology Platform FDmiXmore
28.02.2024 – 15:00RHEACELL GmbH und Co. KGResearch Success in Rare Disease / RHEACELL receives positive signal for accelerated stem cell development program in rare ‚Butterfly Disease‘more
28.02.2024 – 11:07Helmholtz Zentrum MünchenRising Focus on 'Inceptor' as a Type 2 Diabetes Therapeutic Targetmore
23.02.2024 – 10:28Leipzig Tourismus und Marketing GmbH5Pioneering Heart Surgery and Medical Congresses in LeipzigOne documentmore
22.02.2024 – 13:23Helmholtz Zentrum MünchenTherapeutic Vaccine for Chronic Hepatitis B Enters Clinical TrialMore information on the therapeutic vaccine TherVacBmore
19.02.2024 – 17:05Helmholtz Zentrum MünchenWhat Our Genetic Information Tells Us About Type 2 Diabetes Risk and ComplicationsLearn more about research at Helmholtz Munichmore
18.01.2024 – 10:00ARTTIC Innovation GmbH2OPTIMA cancer project announces the Region Uppsala as new partnerCheck out the OPTIMA Videomore
08.12.2023 – 11:13Helmholtz Zentrum MünchenNew Source of Stem Cells in Injury-Affected Brains of Patientsmore
12.10.2023 – 14:01ARTTIC Innovation GmbH3EU Provides 1 Mio. to Researchers to Advance Personalised OncologycanSERV CallOne documentmore
07.09.2023 – 08:38OD-OS GmbHOD-OS GmbH at ESCRS 2023: Recent MDR certification of Navilas® underlines its advanced standard in retina lasers and opens path to new developmentsmore
30.08.2023 – 12:28STADA Arzneimittel AG2Press release : People with Parkinson’s experience variations in effects of oral medicines, but lack advice, international survey revealsOne documentmore
09.08.2023 – 16:52Helmholtz Zentrum MünchenA New Ally in Fighting Brain Diseases: Our Very Own Skullmore
08.08.2023 – 08:00ARTTIC Innovation GmbH4PIONEER Big Data in Prostate Cancer Platform Opens up to Asian Data SetsMore about PIONEERmore
30.06.2023 – 10:09ARTTIC Innovation GmbH2CARAMBA: New Hope for Multiple Myeloma PatientsCARAMBA project websitemore
27.06.2023 – 11:23RHEACELL GmbH und Co. KGRHEACELL announces “First Patient In”: EB-Haus in Salzburg, Austria starts pivotal study for stem cell therapy for severe forms of Epidermolysis bullosa that is longed for by those affectedmore
15.06.2023 – 09:36Berlin CuresBerlin Cures Welcomes Oliver von Stein as New CEO to Lead Next Phase of Innovation and Growth / Phase II study for BC 007 in the indication Long COVID to start in Junemore
08.05.2023 – 09:00Lysando AGAmicogen and Lysando: Novel approach for the treatment of mastitis in dairy cowsmore
23.03.2023 – 12:04hubergroup Deutschland GmbH5Press Release - hubergroup India expands its support for rural healthcareMore about hubergroupOne documentmore
09.03.2023 – 10:00Medias Klinikum GmbH & Co KGThe world's first Extended Isolated Stopflow Limb Infusion (EISLI) to treat osteosarcoma results in complete remissionmore
01.03.2023 – 13:14ARTTIC Innovation GmbH2Free Access to Cancer Research Services - canSERV 1st Call for ProposalscanSERV websitemore
28.02.2023 – 19:00ARTTIC Innovation GmbHFree Access to Cancer Research Services - canSERV 1st Call for ProposalsAPPLY NOW!One documentmore
27.02.2023 – 13:20Helmholtz Zentrum MünchenType 1 Diabetes Awareness Campaign - K1DS ARE HEROES - startedmore
08.02.2023 – 13:26BrainRepair UGBreakthrough - EUR 50 million investment for start-up BrainRepair UG / Pivotal trial on stem cell treatment for brain damage in newborns fully fundedmore
09.11.2022 – 10:39RHEACELL GmbH und Co. KGStem cell therapy for “Butterfly disease” / RHEACELL receives ‘Partners in Progress Award’ from debra of America for Epidermolysis Bullosa researchmore
25.10.2022 – 09:00Metrics in BalanceMetrics in Balance und DNA Talks schließen sich zusammen und betreten den europäischen Lifestyle-Markt unter einem neuen Namen: LifeTalksmore
20.10.2022 – 12:00Klinik für Prostata-Therapie HeidelbergFocal therapy for prostate cancer: Reliable diagnosis leads to gentle treatmentmore
14.10.2022 – 17:26Helmholtz Zentrum MünchenSwitching tracks: Changing the trafficking of the glucagon receptor in the liver regulates its metabolic signalingHelmholtz Munich Newsroommore
06.10.2022 – 14:01ARTTIC Innovation GmbH2OPTIMA announces AstraZeneca and MUTABOR as official partnersOPTIMA videomore